Valeant Pharmaceuticals International, Inc. v. Silbersher

(1) Whether a relator can avoid the False Claims Act"s public disclosure bar by "stitching together" public disclosures; and (2) whether inter partes review"which this court and the U.S. Court of Appeals for the Federal Circuit have described as a hearing between the federal government and the patent owner"constitutes a channel for public disclosure, either because the government is a "party" to inter partes review, or because that review is a "Federal ... hearing."